Endocrinology, Vol 133, 2803-2808, Copyright © 1993 by Endocrine Society

ARTICLES

Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system

MT Dattani, PC Hindmarsh, CG Brook, IC Robinson, T Weir and NJ Marshall
Endocrine Unit, University College London Medical School, United Kingdom.

The effects of ionic zinc (Zn2+) on human (h) GH bioactivity have been examined using a lactogenic bioassay. The potencies of pituitary- derived hGH (IRP 80/505), recombinant 22K hGH (IRP 88/624), pituitary- derived human PRL (IRP 84/500), and a recombinant methionyl 20- kilodalton variant of hGH in the presence of selected concentrations of ZnCl2 were investigated with an eluted stain assay that uses Nb2 rat lymphoma cells. This precise colorimetric bioassay is based upon the reduction of a yellow tetrazolium salt, 3-[4,5-dimethyl-thiazol-2- yl]2,5-di-phenyl-tetrazolium bromide, to its purple formazan by lactogen-activated Nb2 cells. Zinc (6-100 microM) enhanced the bioactivity of low doses (< 0.045 nM) of both pituitary-derived and recombinant 22K hGH, although the magnitude of enhancement was considerably less than might have been anticipated from previous binding studies (13). Higher concentrations of pituitary-derived hGH (> 0.045 nM) were inhibited by Zn2+. The bioactivity of recombinant methionyl 20K hGH was greatly enhanced by zinc (3-100 microM). In contrast to hGH, the bioactivity of hPRL was not potentiated by Zn2+. These discriminatory effects of Zn2+ when stimulating via the lactogenic receptor are in concordance with the results of previous radioligand binding studies (13). The striking enhancement of 20K hGH lactogenic bioactivity was observed at Zn2+ concentrations within the physiological range for normal human serum (5-20 microM).

This article has been cited by other articles:

				K.M. Duda and C.L. Brooks Differential effects of zinc on functionally distinct human growth hormone mutations Protein Eng. Des. Sel., July 1, 2003; 16(7): 531 - 534. [Abstract] [Full Text] [PDF]

				S. Kinet, S. Bernichtein, P. A. Kelly, J. A. Martial, and V. Goffin Biological Properties of Human Prolactin Analogs Depend Not Only on Global Hormone Affinity, but Also on the Relative Affinities of Both Receptor Binding Sites J. Biol. Chem., September 10, 1999; 274(37): 26033 - 26043. [Abstract] [Full Text] [PDF]

				B. Tsunekawa, M. Wada, M. Ikeda, H. Uchida, N. Naito, and M. Honjo The 20-Kilodalton (kDa) Human Growth Hormone (hGH) Differs from the 22-kDa hGH in the Effect on the Human Prolactin Receptor Endocrinology, September 1, 1999; 140(9): 3909 - 3918. [Abstract] [Full Text]

				M. T. Dattani, P. C. Hindmarsh, C. G. D. Brook, I. C. A. F. Robinson, J. J. Kopchick, and N. J. Marshall G120R, a Human Growth Hormone Antagonist, Shows Zinc-dependent Agonist and Antagonist Activity on Nb2 Cells J. Biol. Chem., April 21, 1995; 270(16): 9222 - 9226. [Abstract] [Full Text] [PDF]